Evaluating the Benefits and Harms of Anticoagulation in Patients With Atrial Fibrillation

Mark H. Ebell MD, MS

Disclosures

Am Fam Physician. 2018;98(12):751-753. 

In This Article

Clinical Question

In patients with nonvalvular atrial fibrillation (NVAF), what is the best way to determine if the benefits of stroke reduction exceed the harms of bleeding from anticoagulants?

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....